Cyclerion Therapeutics Inc

CYCN NASDAQ
9.78
+0.18
+1.88%
盘后: 9.78 0 0.00% 16:23 06/14 EDT
开盘
9.48
昨收
9.60
最高
10.21
最低
9.35
成交量
24.62万
成交均量(3M)
16.36万
52周最高
22.85
52周最低
9.10
换手率
0.90%
市值
2.68亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Cyclerion Therapeutics Inc CYCN股票价格,Cyclerion Therapeutics Inc股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing treatments for serious and orphan diseases. The Company develops guanylate cyclase (sGC) stimulators. The Company’s portfolio includes five sGC stimulator programs: olinciguat, praliciguat, IW-6463 and two organ-targeted programs. Olinciguat is an oral, once-daily vascular sGC stimulator for patients suffering from sickle cell disease. Olinciguat is in Phase II trial. Praliciguat is an oral, once-daily systemic sGC stimulator for heart failure with preserved ejection fraction (HFpEF) and for diabetic nephropathy. Praliciguat is in two separate Phase II trials. IW-6463 is a central nervous system-penetrant oral sGC stimulator. IW-6463 is in a Phase I and is designed to treat serious and orphan neurodegenerative diseases. Its two organ-targeted programs are designed to address serious and orphan diseases of the liver and lung.
展开 >

最近浏览

名称
价格
涨跌幅